
Company | Value | Change | %Change |
---|
Revenue from transaction charges stood at ₹3,445 crore, down 4% quarter-on-quarter, as lower trading volumes impacted earnings. Operating EBITDA rose 50% year-on-year and 2% quarter-on-quarter to ₹3,398 crore, supported by cost controls. Net profit surged 94% year-on-year and 22% quarter-on-quarter to ₹3,834 crore, reflecting improved profitability.
Trading activity saw a decline, with average daily traded volume (ADTV) for the cash market falling 19% quarter-on-quarter. The ADTV for the futures segment dropped 15% quarter-on-quarter, while equity options ADTV declined 7% quarter-on-quarter.
Also Read: Thyrocare Technologies Q3 Results | Net profit, revenue show healthy growth
Earnings per share (non-annualized) rose to ₹15.49 from ₹12.68 in Q2FY25, factoring in the 4:1 bonus share issuance. Excluding gains from subsidiary investment sales, SEBI settlement fees, and the reversal of provisions for the core Settlement Guarantee Fund (SGF) in Q2FY25, normalised profit before tax declined 3% quarter-on-quarter to ₹3,770 crore.
9MFY25
For 9MFY25, NSE’s consolidated total income rose 30% year-on-year to ₹14,780 crore, with a net profit of ₹9,538 crore. Earnings per share for 9MFY25 stood at ₹38.54, up from ₹23.51 in the same period last year. For the 9MFY25 period, standalone total income stood at ₹13,964 crore, with operating revenue at ₹12,038 crore. Operating EBITDA was ₹7,799 crore, and net profit stood at ₹7,205 crore.
During 9MFY25, NSE contributed ₹45,499 crore to the exchequer, including ₹37,271 crore in Securities Transaction Tax (STT) and Commodities Transaction Tax (CTT), ₹2,976 crore in stamp duty, ₹1,613 crore in SEBI fees, ₹2,173 crore in income tax, and ₹1,466 crore in GST. Of the total STT/CTT collection, 61% came from the cash market and 39% from the equity derivatives segment.
Also Read: HFCL Q3 Results | Net profit and revenue drop, margin rises
First Published: Feb 4, 2025 3:58 PM IST